Unknown

Dataset Information

The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic.


ABSTRACT: Since the outbreak of coronavirus disease 2019 (COVID-19) was first identified, the world has vehemently worked to develop treatments and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented speed. Few of the repositioned drugs for COVID-19 have shown that they were efficacious and safe. In contrast, a couple of vaccines against SARS-CoV-2 will be ready for mass rollout early next year. Despite successful vaccine development for COVID-19, the world will face a whole new set of challenges including scale-up manufacturing, cold-chain logistics, long-term safety, and low vaccine acceptance. We highlighted the importance of knowledge sharing and collaboration to find innovative answers to these challenges and to prepare for newly emerging viruses.

SUBMITTER: Won JH 

PROVIDER: S-EPMC7767501 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature